CliniSys acquires Orion Imaging

Clinical and laboratory systems specialists, CliniSys has acquired diabetic retinopathy screening solution provider, Orion Imaging.

Diabetic retinopathy is the single largest cause of blindness in the UK and is a problem in all countries where ageing populations and increasing obesity rates are leading to greater numbers of people living with diabetes.

Digital retinopathy cameras provide precise digital images of the eye that can be compared over time. Clinicians are alerted much earlier to deterioration in the patient’s eye than through other screening methods.

David Newell, CliniSys’ group business development director said Orion Imaging was “a great business” and commented: “The combination of the market leading solution for diabetic retinopathy together with the CliniSys infrastructure both in the UK and mainland Europe offers a unique and exciting opportunity. The provision of a market leading solution set for diabetes care is a key component of our ongoing business strategy within chronic disease management.”

Cwmbran-based Orion Imaging was one of four companies in the UK selected to supply specialist software services for the NHS national screening programme for sight threatening diabetic retinopathy. Its diabetic retinopathy screening software is distributed with fundus cameras made by Haag-Streit International.

The company claims over 2000 installations in over 52 countries. Newell said Orion Imaging’s recent wins included a contract for supplying Cheshire and Merseyside.  

Link

National Screening Programme for Sight-Threatening Diabetic Retinopathy